Covidien

(Booth 9113) Covidien of Hazelwood, MO, will feature products from its Imaging Solutions business as it launches a new CT contrast delivery system that offers radiofrequency identification (RFID) technology.

Covidien's RFID approach employs an automatic identification technology to capture, store, and transmit data between its Ultraject unit-dose prefilled contrast media syringe and Optivantage DH power injector.

The combined system is designed to help radiologic technologists deliver the prescribed concentration and programmed dose of contrast media during CT procedures. In addition, the approach indicates if an RFID-labeled syringe has been used, is empty, or has passed its expiration date. This safety capability is designed to reduce opportunities for life-threatening air injections or cross-contamination from more than one use of a given syringe. RFID transponders, or tags, provide the basis of the system.

The Optivantage equipment also facilitates documentation of the contrast used for the exam protocol by printing a label that can be placed into the patient record.